statut_color,statut,statut_name,NCTId,eudraCT,CTIS,completion_year,clinical_trial_title,acronym,intervention_type
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00934986,,,2010,Study of Natural Killer Cells Function in Untreated Patients With Chronic Lymphocytic Leukemia,LLC-NK,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00930085,,,2011,Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients,PROTEOHSEPS,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00925418,,,2011,Randomized Trial Evaluating the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere¬Æ in Patient Treated for Breast or Prostate Cancer.,CRYO1,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00908869,,,2011,"Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b for Antiangiogenic/Antivascular Effect in Adult Advanced Neoplasm",METRO1,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00930410,,,2012,Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct Tumor,EMID,PROCEDURE
üüß,2,2: r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT00918853,,,2012,Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas.,MRP,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00894049,,,2013,A Multicenter Prospective Randomized Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation,ITAC02-01,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02525250,,,2015,Pilot Study Immunomonitoring NK Cells in Patients With Myeloid Malignancies,,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01521702,,,2015,Adjuvant Gemcitabine Versus NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer: a Randomized Multicenter Phase III Study,NEOPAC,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02487836,,,2015,Phase II Trial Evaluating the Efficacy of Laying a Biliary Stent for Producing a Heavy Chemotherapy in Unresectable Pancreatic Adenocarcinomas,PROPAC,DEVICE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01819558,,,2015,Etude Phase I/II d'immunoth√©rapie Par prot√©ine recWT1-A10+AS01B apr√®s Greffe allog√©nique de Cellules Souches,ALLO-WT1,BIOLOGICAL
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02174887,,,2016,"A Unicentric, Open Label, Mechanism of Action Trial, on the Biological Effect of Nab-paclitaxel Combined to Gemcitabine, in Patients With Metastatic Pancreatic Adenocarcinoma",MOAnab1,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01499537,,,2016,Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct in Patients With Malignant or Post-operative Jaundice After Failure or Impossibility to Perform Endoscopic Retrograde Cholangiography,,DEVICE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,,2009-014773-40,,2017,Essai de phase II de preuve du concept : Evaluation de l‚Äôactivit√© anti-cellules souches canc√©reuses du bevacizumab administr√© en combinaison √† la chimioth√©rapie n√©oadjuvante dans les cancers du sein,,
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01942980,,,2017,Double-blind Randomized Multicenter Phase III Study Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast Cancer.,,RADIATION
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01190345,,,2017,"Phase II"" Proof of Concept "" Trial Evaluating Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab in Combination With Chemotherapy in Breast Cancer",AVASTEM,DRUG
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT01692873,,,2017,Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004,PACAomics,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02526134,,,2017,Placing Trust in Endoscopic Ultrasonography: Impact on Planning Conformal Radiotherapy of Cancer of the Esophagus and Rectum,FIDUCOR,DEVICE
üüß,2,2: r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT01853358,,,2018,Phase I of Infusion of Selected Donor NK Cells After HLA Identical Allogeneic Stem Cell Transplantation Prepared With Reduced Intensity Conditioning - DLI-NK/IPC 2012-003,DLI-NK,BIOLOGICAL
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT03686592,,,2019,Psychological Effect of the pancr√©atectomy: a Feeling of Strangeness,REPPSE,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01939327,,,2020,"A Phase II Single-arm, Open-label Study to Evaluate the Safety and Efficacy of Combination Lenalidomide (Revlimid¬Æ) With Rituximab in Subjets With Relapsed or Refractory Diffuse Large b Cell Non-Hodgkin's Lymphoma.",R2,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,,2014-000758-12,,2020,"Study of pharmacokinetics of intravenous busulfan (Busilvex ¬Æ) in the conditioning allogeneic transplantation in patients with high-risk hematological disease. 
 
 
 Etude de pharmacocin√©tique du Busulfan intra-veineux (Busilvex¬Æ) dans le conditionnement d‚Äôune greffe allog√©nique chez des patients √† haut risque porteurs d‚Äôh√©mopathie.",BX-PK-IPC2013-016,
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02483325,,,2020,Phase II Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex¬Æ) in Patients at High Risk of Carrying Blood Diseases,BX-PK,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02623309,,,2021,,,BIOLOGICAL
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT04401046,,,2021,COVID-19 EPIDEMIC Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,COVID-TRAUMA,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT03595800,,,2021,Extension of a Phase III Randomized Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen-HaploMUD-RIC-01,HaploMUD-RIC,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT03679338,,,2022,Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer,RFA-BILIAIRE,DEVICE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT03961893,,,2023,Panoramic Screening by Complete Colonoscopy in the Management of Colorectal Adenomas,G-EYE-ADR,DEVICE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT04112654,,,2023,Prospective Randomized Evaluation of the Contribution of Low-pressure Intra-abdominal Insufflation for Laparoscopic Colic Resection,LoPreCol,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00963521,,,,Pilot Study of Therapeutic Vaccination by Leukemic Blasts in Vitro Differentiated Dendritic Cells From Patients With Acute Myelogenous Leukemia in Complete Remission,,BIOLOGICAL
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00540956,,,,Descriptive Study Evaluating the Presence and Function of Natural Killer Cells in Elderly Patients With Acute Myeloid Leukemia in First Remission.,,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02860793,,,,Role of PTK-7 in Acute Myeloid Leukemias: Impact of PTK7 Serum Marker and ex Vivo Studies to Decipher the Role of PTK7,LAM-PTK7,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00840684,,,,A PHASE I-II MULTICENTER STUDY OF THE CLORETAZINE-DAUNORUBICIN-ARACYTINE COMBINATION FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) WITH UNFAVORABLE CYTOGENETICS,,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00802568,,,,Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation Following Reduced Intensity Conditioning in Treating Patients With Multiple Myeloma,,BIOLOGICAL
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00806767,,,,Phase II Study of Allogeneic Transplant of Hematopoietic Stem Cells From a Compatible Family Donor in the Treatment of Patients Over 55 Years With Hematological Malignancies,,BIOLOGICAL
